ID   STK33_HUMAN             Reviewed;         514 AA.
AC   Q9BYT3; Q658S6; Q8NEF5;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   15-MAR-2017, entry version 130.
DE   RecName: Full=Serine/threonine-protein kinase 33;
DE            EC=2.7.11.1;
GN   Name=STK33;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=11738831; DOI=10.1016/S0378-1119(01)00780-6;
RA   Mujica A.O., Hankeln T., Schmidt E.R.;
RT   "A novel serine/threonine kinase gene, STK33, on human chromosome
RT   11p15.3.";
RL   Gene 280:175-181(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 246-514 (ISOFORM 2).
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=16176263; DOI=10.1111/j.1742-4658.2005.04900.x;
RA   Mujica A.O., Brauksiepe B., Saaler-Reinhardt S., Reuss S.,
RA   Schmidt E.R.;
RT   "Differential expression pattern of the novel serine/threonine kinase,
RT   STK33, in mice and men.";
RL   FEBS J. 272:4884-4898(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=21742770; DOI=10.1158/0008-5472.CAN-11-0778;
RA   Babij C., Zhang Y., Kurzeja R.J., Munzli A., Shehabeldin A.,
RA   Fernando M., Quon K., Kassner P.D., Ruefli-Brasse A.A., Watson V.J.,
RA   Fajardo F., Jackson A., Zondlo J., Sun Y., Ellison A.R., Plewa C.A.,
RA   San Miguel T., Robinson J., McCarter J., Schwandner R., Judd T.,
RA   Carnahan J., Dussault I.;
RT   "STk33 kinase activity is non-essential in KRAS-dependent cancer
RT   cells.";
RL   Cancer Res. 71:5818-5826(2011).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-98; VAL-160; GLU-436; THR-437 AND
RP   GLU-458.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase which phosphorylates
CC       VIME. May play a specific role in the dynamic behavior of the
CC       intermediate filament cytoskeleton by phosphorylation of VIME (By
CC       similarity). Not essential for the survival of KRAS-dependent AML
CC       cell lines. {ECO:0000250, ECO:0000269|PubMed:21742770}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with VIME. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BYT3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYT3-2; Sequence=VSP_017939;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, fetal lung and
CC       heart, followed by pituitary gland, kidney, interventricular
CC       septum, pancreas, heart, trachea, thyroid gland and uterus. Weak
CC       hybridization signals were observed in the following tissues:
CC       amygdala, aorta, esophagus, colon ascending, colon transverse,
CC       skeletal muscle, spleen, peripheral blood leukocyte, lymph node,
CC       bone marrow, placenta, prostate, liver, salivary gland, mammary
CC       gland, some tumor cell lines, fetal brain, fetal liver, fetal
CC       spleen and fetal thymus. No signal at all was detectable in RNA
CC       from tissues of the nervous system. {ECO:0000269|PubMed:11738831,
CC       ECO:0000269|PubMed:16176263}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ303380; CAC29064.1; -; mRNA.
DR   EMBL; AK093251; BAC04109.1; -; mRNA.
DR   EMBL; BC031231; AAH31231.1; -; mRNA.
DR   EMBL; AL833011; CAH56302.1; -; mRNA.
DR   CCDS; CCDS7789.1; -. [Q9BYT3-1]
DR   RefSeq; NP_001275987.1; NM_001289058.1.
DR   RefSeq; NP_001275988.1; NM_001289059.1.
DR   RefSeq; NP_001275990.1; NM_001289061.1. [Q9BYT3-1]
DR   RefSeq; NP_112168.1; NM_030906.3. [Q9BYT3-1]
DR   RefSeq; XP_011518590.1; XM_011520288.2. [Q9BYT3-1]
DR   RefSeq; XP_011518592.1; XM_011520290.2. [Q9BYT3-1]
DR   RefSeq; XP_011518594.1; XM_011520292.2. [Q9BYT3-1]
DR   RefSeq; XP_011518595.1; XM_011520293.2. [Q9BYT3-1]
DR   RefSeq; XP_011518596.1; XM_011520294.1. [Q9BYT3-1]
DR   RefSeq; XP_011518597.1; XM_011520295.2. [Q9BYT3-1]
DR   RefSeq; XP_016873632.1; XM_017018143.1. [Q9BYT3-1]
DR   RefSeq; XP_016873633.1; XM_017018144.1. [Q9BYT3-1]
DR   RefSeq; XP_016873634.1; XM_017018145.1. [Q9BYT3-1]
DR   RefSeq; XP_016873635.1; XM_017018146.1. [Q9BYT3-1]
DR   RefSeq; XP_016873636.1; XM_017018147.1. [Q9BYT3-1]
DR   RefSeq; XP_016873637.1; XM_017018148.1. [Q9BYT3-1]
DR   RefSeq; XP_016873638.1; XM_017018149.1. [Q9BYT3-1]
DR   RefSeq; XP_016873639.1; XM_017018150.1. [Q9BYT3-1]
DR   RefSeq; XP_016873640.1; XM_017018151.1. [Q9BYT3-1]
DR   RefSeq; XP_016873641.1; XM_017018152.1. [Q9BYT3-1]
DR   RefSeq; XP_016873642.1; XM_017018153.1. [Q9BYT3-1]
DR   RefSeq; XP_016873643.1; XM_017018154.1. [Q9BYT3-1]
DR   RefSeq; XP_016873644.1; XM_017018155.1. [Q9BYT3-1]
DR   RefSeq; XP_016873645.1; XM_017018156.1. [Q9BYT3-1]
DR   RefSeq; XP_016873648.1; XM_017018159.1. [Q9BYT3-2]
DR   RefSeq; XP_016873649.1; XM_017018160.1. [Q9BYT3-2]
DR   UniGene; Hs.501833; -.
DR   ProteinModelPortal; Q9BYT3; -.
DR   SMR; Q9BYT3; -.
DR   BioGrid; 122426; 9.
DR   IntAct; Q9BYT3; 4.
DR   STRING; 9606.ENSP00000320754; -.
DR   BindingDB; Q9BYT3; -.
DR   ChEMBL; CHEMBL6005; -.
DR   GuidetoPHARMACOLOGY; 2221; -.
DR   iPTMnet; Q9BYT3; -.
DR   PhosphoSitePlus; Q9BYT3; -.
DR   BioMuta; STK33; -.
DR   DMDM; 74761329; -.
DR   EPD; Q9BYT3; -.
DR   MaxQB; Q9BYT3; -.
DR   PaxDb; Q9BYT3; -.
DR   PeptideAtlas; Q9BYT3; -.
DR   PRIDE; Q9BYT3; -.
DR   DNASU; 65975; -.
DR   Ensembl; ENST00000315204; ENSP00000320754; ENSG00000130413. [Q9BYT3-1]
DR   Ensembl; ENST00000396672; ENSP00000379905; ENSG00000130413. [Q9BYT3-1]
DR   Ensembl; ENST00000447869; ENSP00000416750; ENSG00000130413. [Q9BYT3-1]
DR   GeneID; 65975; -.
DR   KEGG; hsa:65975; -.
DR   UCSC; uc001mgi.3; human. [Q9BYT3-1]
DR   CTD; 65975; -.
DR   DisGeNET; 65975; -.
DR   GeneCards; STK33; -.
DR   HGNC; HGNC:14568; STK33.
DR   HPA; HPA015742; -.
DR   HPA; HPA056855; -.
DR   MIM; 607670; gene.
DR   neXtProt; NX_Q9BYT3; -.
DR   OpenTargets; ENSG00000130413; -.
DR   PharmGKB; PA37900; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00840000129744; -.
DR   HOGENOM; HOG000293198; -.
DR   HOVERGEN; HBG094004; -.
DR   InParanoid; Q9BYT3; -.
DR   KO; K08813; -.
DR   OMA; NETRWII; -.
DR   OrthoDB; EOG091G0BST; -.
DR   PhylomeDB; Q9BYT3; -.
DR   TreeFam; TF314166; -.
DR   SignaLink; Q9BYT3; -.
DR   GenomeRNAi; 65975; -.
DR   PRO; PR:Q9BYT3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000130413; -.
DR   CleanEx; HS_STK33; -.
DR   ExpressionAtlas; Q9BYT3; baseline and differential.
DR   Genevisible; Q9BYT3; HS.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    514       Serine/threonine-protein kinase 33.
FT                                /FTId=PRO_0000232644.
FT   DOMAIN      116    381       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     122    130       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    443    446       Poly-Glu.
FT   ACT_SITE    238    238       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     145    145       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q924X7}.
FT   VAR_SEQ     383    448       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_017939.
FT   VARIANT      60     60       K -> E (in dbSNP:rs60786172).
FT                                /FTId=VAR_061746.
FT   VARIANT      98     98       E -> D (in dbSNP:rs34525052).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041172.
FT   VARIANT     160    160       L -> V (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041173.
FT   VARIANT     436    436       D -> E (in dbSNP:rs3751096).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041174.
FT   VARIANT     437    437       A -> T (in dbSNP:rs3751095).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041175.
FT   VARIANT     458    458       A -> E (in dbSNP:rs35296353).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041176.
FT   CONFLICT    436    437       DA -> ET (in Ref. 3; AAH31231).
FT                                {ECO:0000305}.
FT   CONFLICT    451    451       A -> T (in Ref. 3; AAH31231).
FT                                {ECO:0000305}.
SQ   SEQUENCE   514 AA;  57831 MW;  C251691ECB2DAC1A CRC64;
     MADSGLDKKS TKCPDCSSAS QKDVLCVCSS KTRVPPVLVV EMSQTSSIGS AESLISLERK
     KEKNINRDIT SRKDLPSRTS NVERKASQQQ WGRGNFTEGK VPHIRIENGA AIEEIYTFGR
     ILGKGSFGIV IEATDKETET KWAIKKVNKE KAGSSAVKLL EREVNILKSV KHEHIIHLEQ
     VFETPKKMYL VMELCEDGEL KEILDRKGHF SENETRWIIQ SLASAIAYLH NNDIVHRDLK
     LENIMVKSSL IDDNNEINLN IKVTDFGLAV KKQSRSEAML QATCGTPIYM APEVISAHDY
     SQQCDIWSIG VVMYMLLRGE PPFLASSEEK LFELIRKGEL HFENAVWNSI SDCAKSVLKQ
     LMKVDPAHRI TAKELLDNQW LTGNKLSSVR PTNVLEMMKE WKNNPESVEE NTTEEKNKPS
     TEEKLKSYQP WGNVPDANYT SDEEEEKQST AYEKQFPATS KDNFDMCSSS FTSSKLLPAE
     IKGEMEKTPV TPSQGTATKY PAKSGALSRT KKKL
//
